Fate Therapeutics Inc.

NASDAQ: FATE
Share price (8/13/25): $1.13
Market cap (8/13/25): $130 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

Prospectuses and Registrations Filter

Registration of securities for employees

Registration of securities for employees

Prospectus supplement

Shelf registration

Prospectus supplement for primary offering

Ownership Filter

Valamehr Bahram

Valamehr Bahram

Vanguard Group Inc

News Filter

Reports Second Quarter 2025 Financial Results and Business Updates

Shareholder Vote Results

Appoints Matthew Abernethy, M.B.A., to Its Board of Directors

Reports First Quarter 2025 Financial Results and Business Updates

Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Scanned paper annual report submission

Correspondence with the SEC

Letter from the SEC